354 related articles for article (PubMed ID: 25940402)
1. Carbohydrate-Based Nanocarriers Exhibiting Specific Cell Targeting with Minimum Influence from the Protein Corona.
Kang B; Okwieka P; Schöttler S; Winzen S; Langhanki J; Mohr K; Opatz T; Mailänder V; Landfester K; Wurm FR
Angew Chem Int Ed Engl; 2015 Jun; 54(25):7436-40. PubMed ID: 25940402
[TBL] [Abstract][Full Text] [Related]
2. Phosphonylation Controls the Protein Corona of Multifunctional Polyglycerol-Modified Nanocarriers.
Danner AK; Schöttler S; Alexandrino E; Hammer S; Landfester K; Mailänder V; Morsbach S; Frey H; Wurm FR
Macromol Biosci; 2019 May; 19(5):e1800468. PubMed ID: 30913379
[TBL] [Abstract][Full Text] [Related]
3. How Corona Formation Impacts Nanomaterials as Drug Carriers.
Gupta MN; Roy I
Mol Pharm; 2020 Mar; 17(3):725-737. PubMed ID: 31939673
[TBL] [Abstract][Full Text] [Related]
4. Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona.
Schöttler S; Landfester K; Mailänder V
Angew Chem Int Ed Engl; 2016 Jul; 55(31):8806-15. PubMed ID: 27303916
[TBL] [Abstract][Full Text] [Related]
5. Functionalization of Liposomes with Hydrophilic Polymers Results in Macrophage Uptake Independent of the Protein Corona.
Weber C; Voigt M; Simon J; Danner AK; Frey H; Mailänder V; Helm M; Morsbach S; Landfester K
Biomacromolecules; 2019 Aug; 20(8):2989-2999. PubMed ID: 31268685
[TBL] [Abstract][Full Text] [Related]
6. Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers.
Schöttler S; Becker G; Winzen S; Steinbach T; Mohr K; Landfester K; Mailänder V; Wurm FR
Nat Nanotechnol; 2016 Apr; 11(4):372-7. PubMed ID: 26878141
[TBL] [Abstract][Full Text] [Related]
7. Effects of Protein Corona on Active and Passive Targeting of Cyclic RGD Peptide-Functionalized PEGylation Nanoparticles.
Su G; Jiang H; Xu B; Yu Y; Chen X
Mol Pharm; 2018 Nov; 15(11):5019-5030. PubMed ID: 30222356
[TBL] [Abstract][Full Text] [Related]
8. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
[TBL] [Abstract][Full Text] [Related]
9. Complementary analysis of the hard and soft protein corona: sample preparation critically effects corona composition.
Winzen S; Schoettler S; Baier G; Rosenauer C; Mailaender V; Landfester K; Mohr K
Nanoscale; 2015 Feb; 7(7):2992-3001. PubMed ID: 25599336
[TBL] [Abstract][Full Text] [Related]
10. Multivalency Beats Complexity: A Study on the Cell Uptake of Carbohydrate Functionalized Nanocarriers to Dendritic Cells.
Krumb M; Frey ML; Langhanki J; Forster R; Kowalczyk D; Mailänder V; Landfester K; Opatz T
Cells; 2020 Sep; 9(9):. PubMed ID: 32932639
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilicity Regulates the Stealth Properties of Polyphosphoester-Coated Nanocarriers.
Simon J; Wolf T; Klein K; Landfester K; Wurm FR; Mailänder V
Angew Chem Int Ed Engl; 2018 May; 57(19):5548-5553. PubMed ID: 29479798
[TBL] [Abstract][Full Text] [Related]
12. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles.
Hadjidemetriou M; Al-Ahmady Z; Kostarelos K
Nanoscale; 2016 Apr; 8(13):6948-57. PubMed ID: 26961355
[TBL] [Abstract][Full Text] [Related]
13. Mathematical modeling of the protein corona: implications for nanoparticulate delivery systems.
Dell'Orco D; Lundqvist M; Linse S; Cedervall T
Nanomedicine (Lond); 2014 May; 9(6):851-8. PubMed ID: 24981650
[TBL] [Abstract][Full Text] [Related]
14. Impact of anti-PEG antibodies on PEGylated nanoparticles fate in vivo.
Park K
J Control Release; 2018 Oct; 287():257. PubMed ID: 30243349
[No Abstract] [Full Text] [Related]
15. Pre-adsorption of antibodies enables targeting of nanocarriers despite a biomolecular corona.
Tonigold M; Simon J; Estupiñán D; Kokkinopoulou M; Reinholz J; Kintzel U; Kaltbeitzel A; Renz P; Domogalla MP; Steinbrink K; Lieberwirth I; Crespy D; Landfester K; Mailänder V
Nat Nanotechnol; 2018 Sep; 13(9):862-869. PubMed ID: 29915272
[TBL] [Abstract][Full Text] [Related]
16. Surface roughness influences the protein corona formation of glycosylated nanoparticles and alter their cellular uptake.
Piloni A; Wong CK; Chen F; Lord M; Walther A; Stenzel MH
Nanoscale; 2019 Dec; 11(48):23259-23267. PubMed ID: 31782458
[TBL] [Abstract][Full Text] [Related]
17. How Low Can You Go? Low Densities of Poly(ethylene glycol) Surfactants Attract Stealth Proteins.
Seneca S; Simon J; Weber C; Ghazaryan A; Ethirajan A; Mailaender V; Morsbach S; Landfester K
Macromol Biosci; 2018 Sep; 18(9):e1800075. PubMed ID: 29943446
[TBL] [Abstract][Full Text] [Related]
18. Preservation of the soft protein corona in distinct flow allows identification of weakly bound proteins.
Weber C; Simon J; Mailänder V; Morsbach S; Landfester K
Acta Biomater; 2018 Aug; 76():217-224. PubMed ID: 29885856
[TBL] [Abstract][Full Text] [Related]
19. Anti-polyethylene glycol antibodies alter the protein corona deposited on nanoparticles and the physiological pathways regulating their fate in vivo.
Grenier P; Viana IMO; Lima EM; Bertrand N
J Control Release; 2018 Oct; 287():121-131. PubMed ID: 30138715
[TBL] [Abstract][Full Text] [Related]
20. Plasma protein adsorption and biological identity of systemically administered nanoparticles.
Chen D; Ganesh S; Wang W; Amiji M
Nanomedicine (Lond); 2017 Sep; 12(17):2113-2135. PubMed ID: 28805542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
